Toronto Dominion Bank’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
– Sell
-125
Closed -$14K – 1317
2017
Q4
$14K Sell
125
-1,741
-93% -$174K ﹤0.01% 1161
2017
Q3
$184K Buy
1,866
+1,323
+244% +$128K ﹤0.01% 935
2017
Q2
$55K Buy
543
+34
+7% +$3.67K ﹤0.01% 1043
2017
Q1
$59K Buy
509
+127
+33% +$14.8K ﹤0.01% 1021
2016
Q4
$46K Buy
+382
New +$42.3K ﹤0.01% 1028
2016
Q2
– Sell
-232
Closed -$26K – 1202
2016
Q1
$26K Buy
+232
New +$24.1K ﹤0.01% 1036

Other funds holding CLB

Toronto Dominion Bank's CLB Position: Q1 2018 in Review

Toronto Dominion Bank sold out of Core Laboratories (CLB) in Q1 2018, closing a stake of 125 shares — an estimated $14K sold.

Toronto Dominion Bank first reported a position in CLB in Q1 2016 and held it in 6 quarters. The position peaked at $184K in Q3 2017. 355 funds tracked by Wall St. Rank hold CLB as of Q1 2018.

  • Toronto Dominion Bank reported no remaining Core Laboratories position as of Q1 2018 after selling out during the quarter.
  • Toronto Dominion Bank sold 125 Core Laboratories shares in Q1 2018, an estimated $14K.
  • Toronto Dominion Bank first reported a position in Core Laboratories in Q1 2016 and held it in 6 quarters.
  • Toronto Dominion Bank's Core Laboratories position peaked at $184K in Q3 2017.
  • 355 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2018.

Based on Toronto Dominion Bank's 13F filing for Q1 2018, filed 10 May 2018.